Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 8916749.
- Also identified by PMC identifier 2352484.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine whether xylitol, which reduces the growth of Streptococcus pneumoniae, might have clinical importance in the prevention of acute otitis media. A double blind randomised trial with xylitol administered in chewing gum. Eleven day care nurseries in the city of Oulu. Most of the children had had problems with recurrent acute otitis media. 306 day care children: 149 children in the sucrose group (76 boys; mean (SD) age 4.9 (1.5) years) and 157 in the xylitol group (80 boys; 5.0 (1.4) years). Either xylitol (8.4 g a day) or sucrose (control) chewing gum for two months. The occurrence of acute otitis media and antimicrobial treatment received during the intervention and nasopharyngeal carriage of S pneumoniae. During the two month monitoring period at least one event of acute otitis media was experienced by 31/149 (20.8%) children who received sucrose compared with 19/157 (12.1%) of those receiving chewing gum containing xylitol (difference 8.7%; 95% confidence interval 0.4% to 17.0%; P = 0.04). Significantly fewer antimicrobials were prescribed among those receiving xylitol: 29/157 (18.5%) children had at least one period of treatment versus 43/149 (28.9%) (difference 10.4%; 0.9% to 19.9%; P = 0.032). The carriage rate of S pneumoniae varied from 17.4% to 28.2% with no difference between the groups. Two children in the xylitol group experienced diarrhoea, but no other adverse effects were noted among the xylitol users. Xylitol seems to have a preventive effect against acute otitis media.
Medical subject headings
- Control Groups
- Otitis Media
- Risk Assessment
- Xylitol